{"lastClose": 5.659999847412109, "len": 1113, "date": "2023-03-15", "alpha_1": -0.31737164323659883, "beta_1": 1.6210851775851778, "drawup_1": 1.5486725887776869, "natr_1": 15.028959675217793, "sup_1": -0.33156656455948436, "res_1": 0.4128386582958997, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE", "SPINNINGTOP"], "rsi_1": 30.09900087001565, "adx_1": 31.090465541772197, "drawdown_1": -0.6753472273962363, "stratHoldSharpe_1": -0.058705359838617834, "stratHoldAlpha_1": 250.95901942151156, "stratHoldDrawdown_1": -0.6430933191362072, "alpha_3mo": -0.06125960210642856, "beta_3mo": 1.8800158835335747, "drawup_3mo": 0.4608541290620036, "natr_3mo": 15.028959675217793, "sup_3mo": -0.05064780211201226, "res_3mo": 0.16372207076510747, "bullPattern_3mo": ["LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 21.768696891020276, "adx_3mo": 7.510706491770123, "drawdown_3mo": -0.3166869540258124, "stratHoldSharpe_3mo": -1.0075359119874783, "stratHoldAlpha_3mo": 250.40886911483466, "stratHoldDrawdown_3mo": -0.28960394908979636, "Sector": "Health Care", "Name": "Allogene Therapeutics Inc.", "Country": "United States", "Market Cap": 816229472, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "IPO Year": 2018.0, "alpha%_1": 0.19358885992417268, "beta%_1": 0.8999616237233636, "drawup%_1": 0.997390642941784, "natr%_1": 0.9999860165318334, "drawdown%_1": 0.06286776699037656, "stratHoldSharpe%_1": 0.4542993084646734, "stratHoldAlpha%_1": 0.41759292662238423, "stratHoldDrawdown%_1": 0.049033287131667096, "alpha%_3mo": 0.303244960209356, "beta%_3mo": 0.9318846009257522, "drawup%_3mo": 0.8936449517189602, "natr%_3mo": 0.9999807695063493, "drawdown%_3mo": 0.08742331830494332, "stratHoldSharpe%_3mo": 0.23613990900591275, "stratHoldAlpha%_3mo": 0.12809272436656777, "stratHoldDrawdown%_3mo": 0.08874726060861837}